Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 12291 record(s)

Req # A-2020-000401

All documents from general directions up regarding the risks of coronavirus contamination among seniors in long-term care centres and seniors' residences in Quebec and the rest of Canada. Final copies from Dec. 15, 2019 to June 22, 2020.

Organization: Health Canada

12 page(s)
January 2021

Req # A-2019-001367

Adverse Reaction Report (AER). Report number: E2B_02341462.

Organization: Health Canada

24 page(s)
January 2021

Req # A-2020-000629

Copies of any documents showing the allocation and distribution of personal protective equipment (PPE) acquired by the federal government, including breakdowns by province from March 15, 2020 to July 27, 2020.

Organization: Health Canada

166 page(s)
January 2021

Req # A-2020-000139

Adverse Reaction Reports (AERs). Report numbers: E2B_02953143, E2B_02953154, E2B_02953518, E2B_02960043.

Organization: Health Canada

118 page(s)
January 2021

Req # A-2016-001747

Adverse Reaction Reports (AERs) for Diclectin. Report numbers: 000541568, 000640670, 000669055, 000669179, 00670872, 000678548, E2B_00575826, E2B_00593257, E2B_00709057.

Organization: Health Canada

160 page(s)
January 2021

Req # A-2019-000282

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 18-119991-639.

Organization: Health Canada

15 page(s)
January 2021

Req # A-2019-000940

Adverse Reaction Reports (AERs). Report numbers: E2B_00815168, E2B_01261767, E2B_01639359, E2B_01893840, E2B_01836677, E2B_01610888, E2B_01706029, E2B_01708701, 000657419, E2B_02053529, 000491763, E2B_00034322, E2B_00034281, 000491772.

Organization: Health Canada

143 page(s)
January 2021

Req # A-2019-001190

Adverse Reaction Reports (AERs) for HYDROXYCHLOROQUINE SULFATE. Report numbers: E2B_02037310, E2B_02127356, E2B_02128458, E2B_02130341, 000718772, E2B_02174782, 000718874, E2B_02225719, E2B_02225758, E2B_02180913, 000712978, 000719648, 000719746, E2B_01497087, E2B_02142019, E2B_02273303, E2B_02277902.

Organization: Health Canada

1886 page(s)
January 2021

Req # A-2019-001191

Adverse Reaction Reports (AERs) for HYDROXYCHLOROQUINE SULFATE. Report numbers: E2B_02139188, E2B_02096775, E2B_02101008, E2B_02102951, E2B_02123298, E2B_02123654, E2B_02123790, E2B_02123841, E2B_02134309, E2B_01995214, E2B_02139539, E2B_01990951, E2B_02140918, E2B_02015361, E2B_02135489.

Organization: Health Canada

1129 page(s)
January 2021

Req # A-2019-001364

Adverse Reaction Reports (AERs). Report numbers: E2B_02475471, E2B_02414940.

Organization: Health Canada

36 page(s)
January 2021
Date modified: